Caroline is a commercial leader at GSK with over a decade of experience in traditional marketing and sales roles across multiple disease areas. She has built her career at the intersection of commercial strategy and execution, with a strong track record in developing teams and preparing organizations for successful product launches. Over the past two years, she has increasingly focused on the impact of artificial intelligence on the pharmaceutical industry, deliberately immersing herself in the tech ecosystem to better understand emerging developments. While not a technologist by background, Caroline brings a commercial lens to these changes, translating how AI is reshaping decision making, operating models, and the roles of marketing, sales, medical, and market access functions in pharma. Caroline Schwaer | LinkedIn

‍

MedTech, healthcare and AI strategist & governance expert with a proven track record in digital transformation, driving growth, deep change, and restructuring initiatives for governments, organizations, and startups. My experience spans working with investors, boards, ministries, blue-chip multinationals, patient groups and scale-ups globally — including the USA, GCC, India, and APAC — across sectors such as AI, GenAI, ethics, value-based healthcare, digital health, ICT/IV and innovation.

‍

Elliot Leavy is a strategist and speaker at the coalface of artificial intelligence, helping organisations translate agentic AI into scalable business value. As the founder of Acquainted, Europe’s first Generative AI consultancy, he advises global institutions on navigating the Intelligence Age. Elliot is also the author of the Machinepower Index, a definitive framework for assessing national AI sovereignty. By bridging geopolitical strategy with practical implementation, he provides a pragmatic roadmap for leaders looking to lead in the Age of AI.

‍

Kaity Kalkbrenner is a healthcare analytics and strategy leader with more than 15 years of experience helping life sciences organizations turn data into strategic advantage. She has been an active shaper of AI enablement at Real Chemistry and across the healthcare communications industry, advancing how insight, analytics, and technology drive decision‑making. Today, Kaity leads Real Chemistry’s Swiss office, bringing the firm’s global capabilities to both local and international clients navigating complex scientific and commercial challenges.

‍

Brandon is a scientific communications strategist and entrepreneur with a 20-year history in the healthcare industry, bridging the realms of art, science, and education. His foundation in medicine began with earning a Master of Science in Medical Illustration at Augusta University (formerly the Medical College of Georgia). In the 2 decades that followed, he developed and led creative teams that specialized in translating complex biomedical concepts into clear, compelling visual narratives and industry-defining educational experiences. His passions for health, technology, and art have also led to creative innovations in the use of AI to facilitate dialog between patients, caregivers, and healthcare professionals.Currently, as President, Europe, at Real Chemistry, Brandon oversees the agency's European presence, including locations in Zurich, Switzerland and Munich, Germany.

I'm a PharmD and MSc in Statistics, currently a resident in medical biology at the Institut de Cancérologie de Lorraine, where I work on molecular diagnostics and cancer genetics. Over the years, I've had the chance to explore how AI can support clinical practice, from leading a computer vision team focused on cancer cell detection in the USA, to contributing to research at EPFL and the Swiss Institute of Bioinformatics.Alongside my clinical training, I've been involved in several national tasks forces on AI in medical laboratories and health data governance, and I teach bioinformatics and AI applied to cancer genomics diagnostics and theranostics at Paris-Saclay University. I'm also Vice-President for Medical Biology at FNSIP-BM, the national federation of medical biology residents in France.I'm passionate about making AI genuinely useful at the bedside and in the lab, not as a buzzword, but as a practical tool that can improve patient care. I'm really glad to be part of this panel and to learn from everyone here.